Fiserv Inc. Common Stock vs GSK plc — how do they compare? Fiserv Inc. Common Stock trades at $46.2 (market cap $24.50B), while GSK plc trades at $48.85 (market cap $96.45B). The key difference: GSK plc is far larger — about 3.9× Fiserv Inc. Common Stock's market cap, and GSK plc pays a 3.79% dividend while Fiserv Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Fiserv Inc. Common Stock for 0 Days and GSK plc for 93 Days on average.
| FISV | GSK | |
|---|---|---|
Market Cap | $24.50B | $96.45B |
Volume | 3,682,634 | 7,087,457 |
Sector | Technology | Health |
52-Week High | $126.54 | $61.18 |
52-Week Low | $44.36 | $43.24 |
Typical Hold Time | 0 Days | 93 Days |
Enterprise Value | $52.29B | $116.51B |
Dividend Yield | — | 3.79% |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
GSK trades at $46.27, down 1.39% today, with a bearish technical signal from moving averages. The company shows strong profitability with 72.73% gross margins and 14.52% net income margin, supported by three consecutive quarterly earnings beats. Recent developments include a $750M cancer therapy acquisition and strategic focus on oncology growth targeting £40B in sales. Cash flow trends show consistent operational strength with $7.7B from operations in 2025.
GSK presents a mixed outlook with strong fundamentals offset by technical weakness. The stock offers value with a 14.84 P/E ratio and dividend yield, but faces headwinds from HIV patent expirations and bearish technical indicators. Analyst consensus leans cautious with 55% hold ratings, suggesting patience may be warranted despite the company's solid operational performance.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Fiserv, Inc. is a global provider of payments and financial services technology, offering merchant acquiring, digital commerce, and financial solutions through its Merchant Solutions and Financial Solutions segments.
Read more on FISV →In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, cancer, and antiviral, as well as vaccines. GSK uses joint ventures to gain additional scale in certain markets like HIV.
Read more on GSK →